Newswise — ALPCO, a leading producer of research and clinical immunoassays, provides an FDA Class I Exempt Pancreatic Elastase ELISA that can reliably measure PE-1 and, in turn, help laboratories save valuable resources. The company will promote the colorimetric ELISA at the AACC’s 70th Clinical Lab Expo in Chicago July 31 - August 2, 2018. The Pancreatic Elastase ELISA features superior specificity for measuring the PE-1 isoform which is found in stool and can be used to help define exocrine pancreatic function and diagnose pancreatic insufficiency.
“Some pancreatic elastase assays on the market are not specific enough to the PE-1 isoform; while those that are specific to PE-1 are not cost effective,” explains ALPCO’s president, Sean Conley. “Our Pancreatic Elastase ELISA is an affordable solution to reliably measure PE-1 and better help those with pancreatic diseases, as it was designed with a monoclonal antibody system to enhance the specificity to PE-1.”
Additionally, the Pancreatic Elastase ELISA is compatible with an Easy Stool Extraction Device which streamlines sample extraction and processing. The assay is also automatable, further enabling an increase in productivity and reduction in turnaround times.
Visit ALPCO in booth #3467 at the AACC’s 70th Clinical Lab Expo to learn how the Pancreatic Elastase ELISA can help save laboratories time and resources.
About ALPCO
American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of immunoassay-based products for the North American life science markets. The company has since grown into a premier channel representing over 60 collaborating partners from around the globe. Today, ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with vital tools for advancing research and improving quality of care.
RSS